A detailed history of Nomura Holdings Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Nomura Holdings Inc holds 30,141 shares of LLY stock, worth $23.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
30,141
Previous 46,363 34.99%
Holding current value
$23.5 Million
Previous $42 Million 36.39%
% of portfolio
0.06%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $12.5 Million - $15.6 Million
-16,222 Reduced 34.99%
30,141 $26.7 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $15.3 Million - $19.2 Million
21,162 Added 83.97%
46,363 $42 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $14.9 Million - $20 Million
25,201 New
25,201 $19.6 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $5.71 Million - $6.73 Million
10,863 Added 222.83%
15,738 $9.17 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $4.35 Million - $6 Million
-10,012 Reduced 67.25%
4,875 $2.62 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $4.38 Million - $5.86 Million
12,489 Added 520.81%
14,887 $6.98 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $3.56 Million - $4.18 Million
-11,464 Reduced 82.7%
2,398 $823,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $4.59 Million - $5.34 Million
-14,260 Reduced 50.71%
13,862 $5.07 Million
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $8.34 Million - $9.5 Million
28,122 New
28,122 $9.1 Million
Q1 2022

May 18, 2022

SELL
$234.69 - $291.66 $2.76 Million - $3.42 Million
-11,741 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $1.63 Million - $2.02 Million
-7,253 Reduced 38.19%
11,741 $3.24 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $2.37 Million - $2.91 Million
10,686 Added 128.62%
18,994 $4.36 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $891,555 - $1.15 Million
4,938 Added 146.53%
8,308 $1.91 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $4.16 Million - $5.39 Million
-25,345 Reduced 88.26%
3,370 $629,000
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $11.3 Million - $15 Million
-86,970 Reduced 75.18%
28,715 $4.85 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $14.4 Million - $16.6 Million
98,171 Added 560.53%
115,685 $17.1 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $620,165 - $746,362
4,546 Added 35.06%
17,514 $2.88 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $1.54 Million - $1.91 Million
12,968 New
12,968 $1.8 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $3.46 Million - $4.29 Million
-29,089 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $2.89 Million - $3.58 Million
27,063 Added 1335.78%
29,089 $3.82 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $95,897 - $104,311
-898 Reduced 30.71%
2,026 $224,000
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $12,297 - $14,354
111 Added 3.95%
2,924 $329,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $5.55 Million - $6.53 Million
-49,859 Reduced 94.66%
2,813 $363,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $1.52 Million - $1.7 Million
14,325 Added 37.36%
52,672 $6.09 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $1.28 Million - $1.6 Million
14,888 Added 63.46%
38,347 $4.13 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $5.45 Million - $6.25 Million
-71,979 Reduced 75.42%
23,459 $1.65 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $5.61 Million - $6.63 Million
-75,631 Reduced 44.21%
95,438 $7.38 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $7.08 Million - $8.36 Million
95,438 Added 126.19%
171,069 $13.8 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $2.14 Million - $2.29 Million
26,086 Added 52.65%
75,631 $6.39 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $3.82 Million - $4.24 Million
49,545
49,545 $4.24 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.